Pandemia da COVID-19 e seu reflexo no rastreamento do câncer de mama no Brasil

Autores/as

  • Uauira de Melo Medeiros Cunha aLaboratório de Epidemiologia e Análise de Dados – Centro Universitário FMABC
  • Kerle Dayana Tavares de Lucena bUniversidade Estadual de Ciências da Saúde de Alagoas.
  • Luiz Vinicius Alcantara Sousa cLaboratório de Epidemiologia e Análise de Dados – Centro Universitário FMABC

DOI:

https://doi.org/10.36311/jhgd.v34.15810

Palabras clave:

Neoplasias de mama, Programas de rastreamento; Políticas Públicas de Saúde, Sistemas de Informação em Saúde, COVID-19

Resumen

Introdução: o câncer de mama tem sido a principal causa de morte entre mulheres no Brasil e no mundo. Durante os anos de isolamento social devido à COVID-19, serviços de saúde, incluindo o rastreamento do câncer de mama, foram suspensos na tentativa de conter a disseminação do vírus, interferindo na detecção e tratamento precoce do câncer de mama, meios efetivos para redução de mortalidade.  

Objetivo: Identificar como a pandemia de COVID-19 interferiu no itinerário terapêutico do câncer de mama nas regiões brasileiras. 

Método: Trata-se de um estudo observacional, de caráter ecológico, realizado através de análise secundária de dados disponíveis no site do Departamento de Informática do Sistema Único de Saúde (DATASUS). 

Resultado: Foram coletadas informações da realização de todos os exames de mamografia bilateral de rastreamento em mulheres de 50 a 69 anos de idade, casos positivos e modalidades terapêuticas no período de 2018 a 2022. Os dados mostraram que a pandemia impactou de forma diferente as regiões brasileiras exigindo estratégias e investimentos diversos para garantir o acesso aos serviços de saúde e minimizar os impactos da pandemia.

Conclusão: Apesar da pesquisa não apresentar resultados estatisticamente significantes, a região sudeste se destacou no registro de casos, mas apresenta uma queda de casos registrados entre 2021 e 2022. Em contrapartida, a região norte apresentou os menores números de casos em todos os anos

Descargas

Los datos de descarga aún no están disponibles.

Referencias

Sung H, Ferlay J, Siegel RL, Laversanne M, et al. GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.

Instituto Nacional de Câncer José Alencar Gomes da Silva. Atlas da mortalidade. Rio de Janeiro: INCA, 2022. Base de dados. Disponível em: https://www.inca.gov.br/app/mortalidade

Instituto Nacional de Câncer José Alencar Gomes da Silva. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação. Rio de Janeiro: INCA, 2019b. Disponível em: https://www.inca.gov.br/publicacoes/livros/situacao-do-cancerde-mama-no-brasilsintese-de-dados-dos-sistemas-de-informacao

Brasil. Ministério da Saúde. Portaria de consolidação nº2, de 28 de setembro de 2017. Consolidação das normas sobre as políticas nacionais de saúde do Sistema Único de Saúde. Brasília, DF: Ministério da Saúde, 2017a. Anexos IX e XXII. Disponível em: http://bvsms.saude. gov.br/bvs/saudelegis/gm/2017/prc0002_03_10_2017.html

Instituto Nacional de Câncer José Alencar Gomes da Silva. Detecção precoce do câncer / Instituto Nacional de Câncer José Alencar Gomes da Silva. – Rio de Janeiro: INCA, 2021.

Instituto Nacional de Câncer. Diretrizes para a detecção precoce do câncer de mama no Brasil. Rio de Janeiro, 2015.

Migowski A. et al. Diretrizes para detecção precoce do câncer de mama no Brasil. II - Novas recomendações nacionais, principais evidências e controvérsias. Cadernos de Saúde Pública, Rio de Janeiro, 2018;34(6): p.74817

Lowry KP.et al. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Radiology, 2022;303(20):287-294.

Eijkeloom AH.; et al. Impact of the COVID-19 pandemic on the diagnosis, stage and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol,2021; 14(1):64.

Rocha AFBM, et al. COVID-19 and Breast Cancer in Brazil. International Journal of Public Health, 2023; 68(1):1605485.

Tang A. et al. Care in times of COVID-19: impact on breast cancer diagnosis and treatment in a large integrated health care system. Research in Breast Cancer Treatment, 2022;191(1):665-675.

Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nature Reviews. Clinical Oncology, 2020; 17(6):329-331.

Sprague BL, et al. Changes in mammogram use by women’s characteristics during the first 5 months of the COVID-19 pandemic. J Natl Cancer Inst. 2021; 113(9):1161-1167.

The Lancet Oncology. COVID-19: Global consequences for oncology. Lancet Oncol. 2020; 21(4):467.

Sprague BL. et al. Changes in mammogram use by women’s characteristics during the first 5 months of the COVID-19 pandemic. J Natl Cancer Inst. 2021; 113(9):1161-1167.

Rocco N. et al., The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives. The Oncologist, 2021; 26(1): e66-e77.

Al-Shamsi HO. et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncol. 2020; 25(6): e936-e945.

Harky A, Chiu CM, Yau THL, Lai SHD. Cancer Patient Care during COVID-19. Cancer Cell, 2020; 37(6):749-750.

Vanni G. et al. Advanced stages and increased need for adjuvant treatments in breast câncer patients: the effect of the year-long COVID-19 pandemic. Research in Anticancer Actions, 2021; 41(1): 2689-2696.

Schifferdecker KE, et al. Women’s considerations and experiences for breast câncer screening and surveillance during the COVID-19 pandemic in the United States: a focus group study. Preventive Medicine, 2021; 151(1):106542.

Gathani T, et al. The COVID-19 pandemic and the impact on breast cancer diagnoses: what happened in England in the first half of 2020. British Journal of Cancer, 2020; 124(1):710-712.

Gosset M, Gal J, Schiappa R, Dejode M, Fouché Y, Alazet F, et al. Impact de la pandémie de COVID-19 sur les prises em charge pour cancer du sein et gynécologique. Bulletin du Cancer, 2021;108(1):3-11.

Figueroa JD, et al. The impact of the Covid-19 pandemic on breast cancer early detection and screening. Preventive Medicine, 2021; 151(1):106585.

Eijkeloom AH et al. Consortium and the COVID and Cancer-NL Consortium. Impact of the suspension and restart of the Dutch breast cancer screening program on breast câncer incidence and stage during the COVID-19 pandemic. Preventive Medicine, 2021; 151(1):106602.

Wilke LG. et al., Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries. Annals of Surgical Oncology, 2021; 28(10):5535-5543.

Mathelin C. et al. Breast cancer management during the COVID-19 pandemic: research from the Senologic International Society. Eur J Breast Health, 2021; 17(3):188-196.

Tonneson JE, et al. Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management. Annals of Surgical Oncology, 2022; 29(4): 2231- 2239.

Rocco N, et al. The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives. The Oncologist, 2021; 26(1): e66-e77.

Romics L, et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast, 2021; 55(1):1-6.

Li J, Wang H, Geng C, et al. Suboptimal declines and delays in early breast câncer treatment following COVID-19 quarantine restrictions in China: a national survey of 8,397 patients in the first quarter of 2020. EClinical Medicine, 2020; 22(1): 100352.

Sattar AK, et al. Uma abordagem multidisciplinar para triagem de pacientes com doenças da mama durante a pandemia de COVID-19: experiência de um centro de atendimento terciário no mundo em desenvolvimento. Representante do Câncer, 2021; 4(1):e1309.

Brenes Sánchez JM, et al. Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy. Clinical Breast Cancer, 2021; 21(1):e128-e135.

Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nature Reviews. Clinical Oncology, 2020; 17(6):329-331.

Romics L, et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast, 2021; 55(1): 1-6.

Cocco D, Valente SA. Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic. Annals of Surgical Oncology, 2021; 28(7):4056- 4057.

Fortunato L, et al. Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey. Clinical Breast Cancer, 2021; 21(3)0:e165-e167.

Golshan M, et al. Breast Conservation After Neoadjuvant Chemotherapy for TripleNegative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial. JAMA Surg, 2020; 155(3).

Moraes MR. Tendência temporal da realização de mastectomia e de reconstrução de mamas no Brasil no período de 2009 a 2018. Medicina-Pedra Branca, 2020.

Vanni G, et al. Advanced stages and increased need for adjuvant treatments in breast câncer patients: the effect of the year-long COVID-19 pandemic. Research in Anticancer Actions, 2021; 41(1):2689-2696.

Macinnes EG, et al. Breast Cancer Surgery During the COVID-19 Pandemic Peak in the UK: Operative Outcomes. Cureus, 2020; 12(7): e9280.

Curigliano G, et al. Recommendations for screening, prioritization, and treatment of breast cancer patients during the covid-19 pandemic. Breast, 2020; 52(1): 8-16.

Druesne-Pecollo N, et al. Excess body weight and second primary cancer risk after breast cancer: A systematic review and meta-analysis of prospective studies. Breast Cancer Research and Treatment, 2012; 135(1): 647–654.

Courtney A, et al. O estudo b-Map-C: caminhos de gerenciamento do câncer de mama durante a pandemia de covid-19. protocolo de estudo. Int J Surg Protocol, 2020; 24(1): 1-5.

Savard J, Jobin-Théberge A, Massicotte V, Banville C. How did women with breast cancer experience the first wave of the COVID-19 pandemic? A qualitative study. Supportive Care in Cancer, 2021; 29(10): 5721-5727.

Chen G, et al. Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19. Psychooncology, 2020; 29(1): 1395-1398.

Wang Y, et al. Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Translational Psychiatry, 2020; 10(1): 263.

Lally RM, et al. CaringGuidance after breast cancer diagnosis eHealth psychoeducational intervention to reduce early post-diagnosis distress. Supportive Care in Cancer, 2020; 28(1):2163-2174.

Sajjad M, et al. Experiências vividas de “incerteza da doença” de pacientes iranianos com câncer: um estudo hermenêutico fenomenológico. Enfermagem Oncológica, 2016;39(4):E1-E8.

Publicado

2024-07-31

Número

Sección

ORIGINAL ARTICLES